die('
Site is under construction
Dear site users
Site is under construction.
The site will be ready in less than 24 hours.
We are sorry for the inconvenience.
www.yektaweb.com
');
Reports of Biochemistry and Molecular Biology
rbmb.net
Basic Sciences
http://rbmb.net
1
admin
2322-3480
2322-3480
10.61882/rbmb
en
jalali
1400
5
1
gregorian
2021
8
1
10
2
online
1
fulltext
en
Highlighting Levels of Indoxyl Sulphate among Critically Ill Patients with Acute Nephrotoxicity; Correlations Between Indoxyl Sulphate Levels and Patients’ Characteristics
بیوشیمی
Biochemistry
مقالات اصلی
Original Article
<div style="text-align: justify;"><strong>Background:</strong> Many animal studies suggested that the uremic toxin indoxyl sulphate can add to renal damage following induced nephrotoxicity and this effect has not been proved in patients with such complication.<br>
<strong>Methods: </strong>This is a prospective, case-control, and an observational study conducted on 74 critically ill patients with acute nephrotoxicity. It was designed to measure serum levels of indoxyl sulphate on the day of enrollment and over the course of their illness using high performance liquid chromatography (HPLC-UV) and to test the correlation between these levels and patient’s demographics, clinical characteristics, physiological variables, and their outcomes.<br>
<strong>Results: </strong>Critically ill patients with acute nephrotoxicity had significantly higher total (tIS) and free (fIS) indoxyl sulphate than healthy controls and significantly lower than patients with end-stage renal disease (ESRD). Although, no correlation was found between tIS or fIS and mortality, among survivors, tIS, fIS, creatinine and eGFR were independently associated with no renal recovery.<br>
<strong>Conclusions:</strong> Serum indoxyl sulphate levels were elevated in critically ill patients with acute nephrotoxicity. There is an association between high levels of indoxyl sulphate and no renal-recovery outcome among survivors of acute nephrotoxicity. Early removal of indoxyl sulphate from patients’ blood may improve their outcomes.</div>
HPLC, Indoxyl sulphate, Mortality, Prognosis, Toxic acute kidney injury.
266
279
http://rbmb.net/browse.php?a_code=A-10-673-1&slc_lang=en&sid=1
Nermien
Yousef Selim
100319475328460015478
100319475328460015478
No
Medical Research Center, Faculty of Medicine, University of Alexandria, Egypt.
Hazem
Farag Mannaa
amir.monfaredan@yahoo.com
100319475328460015479
100319475328460015479
Yes
Medical Biochemistry Department, Faculty of Medicine, University of Alexandria, Egypt.
Ola
Atef Sharaki
100319475328460015480
100319475328460015480
No
Clinical Pathology Department, Faculty of Medicine, University of Alexandria, Egypt.
Tayseer
Zaytoun
100319475328460015481
100319475328460015481
No
Critical Care Medicine center, Faculty of Medicine, University of Alexandria, Egypt.
Noha
Elkholy
100319475328460015482
100319475328460015482
No
Nephrology Department, Faculty of Medicine, University of Alexandria, Egypt.
Waleed
Arafat
100319475328460015483
100319475328460015483
No
Clinical Oncology Department, Faculty of Medicine, University of Alexandria, Egypt.